News archive - 2016
- Monday, 11 July 2016Regeneus Ltd (ASX:RGS) is on track to enter its first significant partnering agreement in Japan by the end of September for its stem cell product, Progenza.
- Wednesday, 25 May 2016The Life Sciences Report, published by Streetwise Reports, focuses on biotechnology, pharmaceuticals, medical devices, tools and diagnostics.
- Friday, 20 May 2016Regeneus Ltd (ASX:RGS), through its involvement in a research consortium has been awarded a $340,000 grant from the Australian Research Council.
- Wednesday, 18 May 2016
The Australian Research Council (ARC) has awarded a Linkage Grant of $340,000 to a research consortium investigating how stem cells can be used to relieve chronic pain.
- Tuesday, 17 May 2016Clinical-stage regenerative medicine company Regeneus Ltd (ASX:RGS), has outlined the completion of enrolment of all 20 patients in the STEP trial.